CMPS — COMPASS Pathways plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1816590 ·
Last close
$13.06
Market Cap
$1.81B
52W High
$15.87
52W Low
$4.88
ADV30
2,625,480
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -49,789,000 | -253,794,000 | 504,561,000 | 433,295,000 | 420,028,000 |
| Mar 2026 | 0 | — | -40,427,000 | 91,202,000 | 531,739,000 | 466,010,000 | 205,052,000 |
| Dec 2025 | 0 | — | -58,864,000 | -93,878,000 | 210,349,000 | 149,608,000 | 263,197,000 |
| Sep 2025 | 0 | — | -36,612,000 | -137,717,000 | 255,607,000 | 185,937,000 | 218,016,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-161,136,000
Investing CF
$0
Financing CF
$370,200,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.62
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-985,186,000
Inventory
—
Receivables
$15,155,000
ST Investments
—
EBIT TTM
$-391,641,000
Pretax Income TTM
$-396,831,000
Interest Exp TTM
$5,190,000
Analysts
16
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -175,290,000 | -287,862,000 | 210,349,000 | 263,197,000 | -52,848,000 | -157,240,000 |
| Dec 2024 | 0 | -157,108,000 | -155,122,000 | 213,666,000 | 58,971,000 | 154,695,000 | -119,186,000 |
| Dec 2023 | 0 | -124,044,000 | -118,464,000 | 275,987,000 | 50,243,000 | 225,744,000 | -97,376,000 |
| Dec 2022 | 0 | -95,979,000 | -91,505,000 | 197,294,000 | 16,014,000 | 181,280,000 | -105,451,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$4,363,000
NetIncome TTM
$-72,215,000
OpCashFlow TTM
$0
Assets (Latest)
$210,349,000
Forward EPS
$-1.43
Max Pain — expiry 2026-10-16
max pain strike: $15.00 · spot: $13.17 · call oi: 8,581 · put oi: 2,570
Expected Move to 2026-10-16:
±$1.62
(12.34%) —
implied range
$11.54 –
$14.79
· ATM straddle on $13.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| XNCR | Xencor Inc | $1.77B | $23.80 | — |
| SEPN | Septerna, Inc. | $1.76B | $37.77 | — |
| ZBIO | Zenas BioPharma, Inc. | $1.76B | $26.95 | — |
| ZYME | Zymeworks Inc. | $1.88B | $26.52 | — |
| SDGR | Schrodinger, Inc. | $1.89B | $28.85 | — |
News headlines (Yahoo Finance, 1h cache)
Compass Pathways Targets Q4 COMP360 NDA Completion, Eyes 2027 Launch
2026-09-25 00:02 · Yahoo
Compass Pathways Targets 2027 COMP360 Launch After Positive Phase III Depression Data
2026-09-22 21:02 · Yahoo
Compass Pathways Eyes 2027 COMP360 Launch as FDA Review Advances
2026-09-22 19:02 · Yahoo
Compass Pathways Eyes 2027 COMP360 Launch as FDA Filing Nears
2026-09-22 06:02 · Yahoo
Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026
2026-09-16 10:30 · Yahoo
COMPASS Pathways (CMPS) Stock May Be Fully Priced On Phase 3 Data
2026-09-16 06:11 · Yahoo
Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026
2026-09-15 10:30 · Yahoo
Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training
2026-09-10 12:00 · Yahoo
Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training
2026-09-10 10:35 · Yahoo
Compass Pathways to Participate in Investor Conferences the Week of September 14th
2026-09-10 10:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.